SEER-Medicare data (n=54,344; mean age 77.7 years) showed significant unadjusted Black-White gaps in localized diagnosis, ...

Tarik Asselah, MD, PhD, professor of hepatology at Hôpital Beaujon and the University of Paris-Cité, highlighted alcohol-related liver disease and rare liver conditions as chronically underfunded ...

Wastewater signals show BA.3.2 across 25 states, while NWSS funding reductions threaten program continuity after FY2025, diminishing national situational awareness for emerging variants. Genomic ...

“Surgical therapy for diabetic gastroparesis is associated with improved glycemic control and reduced diabetes-related ...

Open-label extension data from 389 ATTRibute-CM completers compared continuous acoramidis with placebo-to-acoramidis ...

OLYMPIA-3 trial at ASCO 2026 shows odronextamab plus CHOP in higher-risk B-cell lymphoma delivers strong MRD-negative CRs ...

The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...

Research presented at the 2026 annual meeting of the American Society of Clinical Oncology (ASCO) add to the growing evidence base for pimicotinib, an oral colony-stimulating factor-1 receptor (CSF-1R ...

The authors describe Medicare Advantage plans that screen for and provide supplemental benefits addressing social needs and ...

Serial KCCQ-TSS decline emerged as the most prominent pre-event signal for sudden death, contrasting with improving symptoms ...

James F. Howard, MD, discusses what he believes will be the next steps in treating myasthenia gravis. CAR-T therapies could ...

Real-world data suggest nirogacestat boosts response in desmoid tumor vs standard-of-care treatment, but small cohorts leave ...